References and Notes
Reviews:
1a
Syamala M.
Org.
Prep. Proced. Int.
2005,
37:
103
1b
Noyori R.
Suzuki M.
Chemtracts
1990,
3:
173
2a
Yar M.
McGarrigle EM.
Aggarwal VK.
Angew. Chem. Int.
Ed.
2008,
47:
3784 ; Angew. Chem. 2008, 120, 3844
2b
Unthank MG.
Tavassoli B.
Aggarwal VK.
Org. Lett.
2008,
10:
1501
2c
Unthank MG.
Hussain N.
Aggarwal VK.
Angew. Chem. Int. Ed.
2006,
45:
7066 ; Angew. Chem. 2006, 118, 7224
3a
Kim K.
Jimenez LS.
Tetrahedron:
Asymmetry
2001,
12:
999
3b
Wang Y.
Zhang W.
Colandrea VJ.
Jimenez LS.
Tetrahedron
1999,
55:
10659
There is one isolated report of
an epoxidation reaction of a butadienylsulfonium salt with a β-keto
ester and aldehyde. See:
4a
Rowbottom MW.
Mathews N.
Gallagher T.
J. Chem. Soc., Perkin Trans.
1
1998,
3927
For a related example using vinyl selenonium salts, see:
4b
Watanabe Y.
Ueno Y.
Toru T.
Bull.
Chem. Soc. Jpn.
1993,
66:
2042
5
Corey EJ.
Oppolzer W.
J. Am. Chem. Soc.
1964,
86:
1899
Nucleophiles with two acidic protons
on the same atom have been shown to react with vinyl sulfonium salts
to give three-membered rings:
6a
Gosselck J.
Béress L.
Schenk H.
Angew.
Chem., Int. Ed. Engl.
1966,
5:
596 ; Angew. Chem. 1966, 78, 606
6b
Johnson CR.
Lockard JP.
Tetrahedron
Lett.
1971,
12:
4589
6c
Takaki K.
Agawa T.
J. Org. Chem.
1977,
42:
3303
6d
Matsuo J.
Yamanaka H.
Kawana A.
Mukaiyama T.
Chem. Lett.
2003,
32:
392
In cases where the nucleophile can be resonance-stabilized forming
enolates, five-membered rings have also been obtained:
6e
Braun H.
Huber G.
Tetrahedron Lett.
1976,
17:
2121
6f
Batty JW.
Howes PD.
Stirling CJM.
J. Chem. Soc., Perkin Trans.
1
1973,
65 ; ref. 6b
For leading references on aziridination
reactions of sulfonium methylides with imines, see:
7a
Aggarwal VK.
Coogan MP.
Stenson RA.
Jones RVH.
Fieldhouse R.
Blacker J.
Eur.
J. Org. Chem.
2002,
319
7b
Aggarwal VK.
Stenson RA.
Jones RVH.
Fieldhouse R.
Blacker J.
Tetrahedron Lett.
2001,
42:
1587
For leading references on aziridinations
with other types of sulfur ylides, see:
8a
McGarrigle EM.
Myers EL.
Illa O.
Shaw MA.
Riches SL.
Aggarwal VK.
Chem.
Rev.
2007,
107:
5841
8b
Hou XL.
Wu J.
Fan RH.
Ding CH.
Luo ZB.
Dai LX.
Synlett
2006,
181
8c
Tang Y.
Ye S.
Sun X.-L.
Synlett
2005,
2720
8d
Aggarwal VK.
Badine DM.
Moorthie VA. In Aziridines
and Epoxides in Asymmetric Synthesis
Yudin AK.
Wiley-VCH;
Weinheim:
2006.
Chap.
1.
Only cis-aziridine was obtained in
the reaction of(dimethylamino)-p-tolyloxosulfonium ethylide
with PhCH=NPh, see:
8e
Johnson CR.
Janiga ER.
J.
Am. Chem. Soc.
1973,
95:
7692
9
Aggarwal VK.
Charmant JPH.
Ciampi C.
Hornby JM.
O’Brien CJ.
Hynd G.
Parsons R.
J. Chem. Soc., Perkin Trans. 1
2001,
3159
10a
Robiette R.
J. Org. Chem.
2006,
71:
2726
10b
Janardanan D.
Sunoj RB.
Chem. Eur. J.
2007,
13:
4805
11
Seebach D.
Golinsky J.
Helv. Chim. Acta
1981,
64:
1413
12 The products were characterized by
NMR, IR, MS, and mp (where appropriate). Satisfactory elemental
analyses and/or HRMS were obtained for all compounds. Full
details and spectra are available from the authors.
13
N
,4-Dimethyl-
N
-{[1-(toluene-4-sulfonyl)-3-phenyl-2-aziridinyl]methyl}benzenesulfonamide
(Table 2, Entry 2)
cis-Isomer
as a colourless oil; R
f
= 0.40 (EtOAc-PE,
3:7). IR (film): 1598 (Ar), 1330 (SO2), 1160 (SO2)
cm-¹. ¹H NMR (400
MHz, CDCl3): δ = 7.86 (2 H, d, J = 8.3 Hz, ArH), 7.50 (2 H,
d, J = 8.3 Hz, ArH), 7.35 (2
H, d, J = 8.3 Hz, ArH), 7.27-7.16
(7 H, m, ArH), 3.93 (1 H, d, J = 7.0
Hz, NCHPh), 3.25-3.14 (2 H, m, NCHH
and NCHCH2), 2.53 (1 H, dd, J = 14.3, 7.0 Hz, NCHH), 2.44 (6 H, s, 2 × CH3),
2.38 (3 H, s, CH3). ¹³C
NMR (100.5 MHz, CDCl3): δ = 145.0 (C),
143.5 (C), 136.2 (C), 135.9 (C), 132.0 (C), 130.0 (CH), 129.9 (CH),
129.7 (CH), 128.6 (CH), 128.3 (CH), 127.4 (CH), 127.3 (CH), 47.6
(CH2), 44.4 (CH), 44.1 (CH), 35.4 (CH3), 21.7
(CH3), 21.5 (CH3). MS (CI): m/z (%) = 471
(14) [MH+], 198 (100) [Ts(Me)NCH2
+]; trans-isomer (obtained as a mixture with cis-isomer) as a colorless oil; R
f
= 0.40 (EtOAc-PE,
3:7). IR (film): νmax = 1599 (Ar),
1332 (SO2), 1161 (SO2) cm-¹. ¹H
NMR (400 MHz, CDCl3): δ = 7.77 (2 H,
d, J = 8.3 Hz, ArH), 7.69 (2
H, d, J = 8.3 Hz, ArH), 7.31 (2
H, d, J = 8.3 Hz, ArH), 7.26-7.19
(7 H, m, ArH), 3.85 (1 H, d, J = 3.8
Hz, NCHPh), 3.55 (1 H, dd, J = 14.6,
8.6 Hz, NCHH), 3.03 (1 H, ddd, J = 8.6, 8.6, 3.8 Hz, NCHCH2N), 2.43 (6 H, s, 2 × CH3),
2.42-2.38 (4 H, m, NCHH and
CH3). ¹³C NMR (100.5 MHz,
CDCl3): δ = 144.9 (C), 143.6 (C), 136.2
(C), 134.0 (C), 132.0 (C), 129.9 (CH), 129.8 (CH), 128.6 (CH), 128.5
(CH), 127.4 (CH), 127.3 (CH), 126.9 (CH), 49.6 (CH), 49.0 (CH2),
48.8 (CH), 36.5 (CH3), 21.7 (CH3), 21.5 (CH3).
MS (CI): m/z (%) = 471
(14) [MH+], 198 (100) [Ts(Me)NCH2
+].
14
Diethyl 2-Methyl-2-({1-[(4-methylphenyl)sulfonyl]-3-phenyl-2-aziridinyl}methyl)malonate
(Table 3, Entry 3)
cis/trans-Isomers (3:1) as a colorless oil
(89%); R
f
= 0.30 (EtOAc-PE,
2:8). IR (film): 1761 (OCO), 1162 (SO2) cm-¹. ¹H
NMR (400 MHz, CDCl3): δ(cis) = 7.85
(2 H, d, J = 8.3 Hz, ArH), 7.32-7.17
(7 H, m, ArH), 4.19-4.02 (4 H, m, 2 × OCH2),
3.87 (1 H, d, J = 7.2 Hz, NCHPh),
2.99-2.91 (1 H, m, NCHCH2), 2.43 (3 H, s, CH3),
1.87 (1 H, dd, J = 14.9, 5.8 Hz,
CHH), 1.70 (1 H, dd, J = 14.9,
6.4 Hz, CHH), 1.31 (3 H, s, CH3),
1.27-1.11 (6 H, m, 2 × CH3). ¹³C
NMR (100.5 MHz, CDCl3): δ = 171.5 (C),
171.4 (C), 144.7 (C), 144.6 (C), 132.4 (C), 129.8 (CH), 129.6 (CH),
128.5 (CH), 128.2 (CH), 127.6 (CH), 61.8 (CH2), 61.6
(CH2), 52.4 (C), 45.1 (CH), 42.7 (CH), 31.1 (CH2),
21.6 (CH3), 19.5 (CH3), 13.9 (CH3),
13.8 (CH3). ¹H NMR (400 MHz, CDCl3): δ(trans) = 7.78 (2 H, d, J = 8.3 Hz, ArH), 7.32-7.17
(7 H, m, ArH), 4.19-4.02 (4 H, m, 2 × OCH2),
3.78 (1 H, d, J = 4.2 Hz, NCHPh),
2.99-2.91 (1 H, m, NCHCH2), 2.49-2.36
(5 H, m, CH2 and CH3), 1.31 (3 H, s, CH3),
1.27-1.11 (6 H, m, 2 × CH3). ¹³C
NMR (100.5 MHz, CDCl3): δ = 171.5 (C),
171.4 (C), 144.4 (C), 143.6 (C), 134.8 (C), 129.8 (CH), 128.8 (CH),
128.5 (CH), 127.4 (CH), 126.7 (CH), 61.8 (CH2), 61.7
(CH2), 52.9 (C), 46.2 (CH), 43.7 (CH), 31.9 (CH2),
21.6 (CH3), 20.7 (CH3), 13.9 (CH3),
13.8 (CH3). MS (CI): m/z (%) = 460
(28) [MH+] , 414 (17) [M+ - EtO],
286 (100) [M+ - C(CO2Et)2Me].
15
1-(4-Toluenesulfonyl)-2-phenyl-3-[(phenylsul-fanyl)methyl]aziridine
(Table 3, Entry 6)
cis:trans-Isomers (1:5) as a colorless oil
(33%); R
f
= 0.45 (EtOAc-PE,
3:7). IR (film): 1347 (SO2), 1164 (SO2) cm-¹. ¹H
NMR (400 MHz, CDCl3): δ(cis) = 7.58
(2 H, d, J = 8.3 Hz, ArH), 7.35-7.08
(12 H, m, ArH), 4.03 (1 H, d, J = 7.0 Hz,
NCHPh), 3.29-3.19 (2 H, m, NCHCHH), 2.62 (1 H, dd, J = 14.2,
7.0 Hz, CHH), 2.36 (3 H, s, CH3). ¹³C
NMR (100.5 MHz, CDCl3): δ = 143.5 (C),
137.0 (C), 135.2 (C), 134.6 (C), 129.8 (CH), 129.7 (CH), 129.1 (CH),
128.8 (CH), 128.1 (CH), 127.7 (CH), 127.1 (CH), 126.6 (CH), 46.2
(CH), 45.1 (CH), 35.4 (CH2), 21.6 (CH3). ¹H
NMR (400 MHz, CDCl3): δ(trans) = 7.81
(2 H, d, J = 8.3 Hz, ArH), 7.35-7.08
(12 H, m, ArH), 4.70 (1 H, d, J = 4.2
Hz, NCHPh), 3.73 (1 H, ddd, J = 7.0,
6.5, 4.2 Hz, NCHCH2), 3.12
(1 H, dd, J = 14.1, 6.5 Hz,
CHH), 2.81 (1 H, dd, J = 14.1,
7.0 Hz, CHH), 2.42 (3 H, s, CH3). ¹³C
NMR (100.5 MHz, CDCl3): δ = 144.7 (C),
137.2 (C), 135.0 (C), 134.4 (C), 129.9 (CH), 129.7 (CH), 129.6 (CH),
129.2 (CH), 129.0 (CH), 128.9 (CH), 128.2 (CH), 127.4 (CH), 48.9
(CH), 46.3 (CH), 35.6 (CH2), 21.7 (CH3). MS
(CI): m/z (%) = 396
(3) [MH+], 224 (100) [MH+ - TsNH2],
155 (16) [Ts+].
16
Diethyl 2-(Acetylamino)-2-{[3-(4-methoxyphenyl)-1-(4-toluene-sulfonyl)-2-aziridinyl]methyl}malonate
(Table 4, Entry 8)
cis-Isomer
as a colorless oil (62%); R
f
= 0.40 (EtOAc-PE, 4:6).
IR (film): 1762 (OCO), 1160 (SO2) cm-¹. ¹H
NMR (400 MHz, CDCl3): δ = 7.79 (2 H,
d, J = 8.3 Hz, ArH), 7.29 (2
H, d, J = 8.3 Hz, ArH), 7.21
(1 H, br s, NH), 6.95 (2 H, d, J = 8.7
Hz, ArH), 6.75 (2 H, d, J = 8.7
Hz, ArH), 4.41-4.09 (4 H, m, 2 × OCH2),
3.74 (1 H, d, J = 7.2 Hz, NCHAr),
3.73 (3 H, s, OCH3), 2.89 (1 H, ddd, J = 10.1,
7.2, 3.7 Hz, NCHCH2), 2.53
(1 H, dd, J = 15.1, 3.7 Hz,
CHH), 2.41 (3 H, s, CH3), 2.10
(1 H, dd, J = 15.1, 10.1 Hz,
CHH), 2.07 (3 H, s, CH3), 1.33-1.15
(6 H, m, 2 × CH3). ¹³C
NMR (100.5 MHz, CDCl3): δ = 169.7 (C),
167.4 (C), 167.2 (C), 159.5 (C), 144.9 (C), 131.1 (C), 129.8 (CH),
128.5 (CH), 128.1 (CH), 123.8 (C), 114.0 (CH), 65.1 (C), 62.9 (CH2),
62.7 (CH2), 55.3 (CH3), 45.1 (CH), 41.1 (CH),
28.9 (CH2), 23.0 (CH3), 21.8 (CH3),
14.0 (CH3), 13.9 (CH3). MS (CI): m/z (%) = 533
(58) [MH+], 320 (100) [MH+ - TsNHAc].